Parkinson's Disease | Community Health

Parkinson's disease is a progressive neurodegenerative disorder that affects both motor and non-motor systems, causing symptoms such as tremors, bradykinesia, rigidity, and postural instability. The disease is characterized by the gradual decay and loss of dopamine-producing neurons in the substantia nigra region of the brain. With no single cause, Parkinson's disease is thought to result from the interaction of genetic and environmental factors, affecting approximately 10 million people worldwide, with 1 million cases in the United States alone. The disease typically develops gradually, with non-motor symptoms such as autonomic nervous system failures, sleep abnormalities, and cognitive impairment becoming more prevalent as the disease progresses. According to the [[national-institutes-of-health|National Institutes of Health]] (NIH), the economic burden of Parkinson's disease in the United States is estimated to be around $52 billion annually. Researchers, including those at the [[mayo-clinic|Mayo Clinic]] and the [[michael-j-fox-foundation|Michael J. Fox Foundation]], are working to develop new treatments and therapies to manage the disease, with a focus on [[stem-cell-therapy|stem cell therapy]] and [[gene-therapy|gene therapy]].